Krishna Institute of Medical Sciences Limited (KIMS) reported its financial and operational highlights for Q4 FY25 and the full financial year 2025.
Financial Highlights FY25:
- Total revenue stood at ₹3,067 crore, a growth of 22% year-on-year.
- EBITDA was ₹815 crore, up 24.7% year-on-year, with EBITDA margins at 26.6%.
- Profit After Tax (PAT) was ₹415 crore, compared to ₹336 crore in FY24.
- Consolidated revenue from operations was ₹3,035 crore, a growth of 21.5% year-on-year.
- Consolidated EBITDA pre-Ind AS was ₹789 crore, a growth of 24% year-on-year.
Financial Highlights Q4 FY25:
- Total revenue reached ₹801 crore, a growth of 25.7% year-on-year.
- EBITDA was ₹203 crore, a growth of 24.4% year-on-year, with EBITDA margins at 25.3%.
- PAT was ₹106 crore, compared to ₹72 crore in Q4 FY24.
- Consolidated revenue from operations was ₹797 crore, a growth of 25.7% year-on-year.
- Consolidated EBITDA pre-Ind AS was ₹195 crore, growth of 24.3% year-on-year.
Operational Highlights FY25:
- Average revenue per operating bed (ARPOB) grew by 22.7% year-on-year.
- Average revenue per patient (ARPP) grew by 9.2% year-on-year.
- In-patient (IP) and Out-patient (OP) volumes grew by 11.6% and 14.1% respectively year-on-year.
- The Telangana cluster showed margin expansion due to revenue growth, new doctor onboarding, and increased volumes from high ARPOB specialties like liver transplants.
New Unit Launches and Expansion:
- Opened new hospitals in Nashik and Sangli (Maharashtra), Kannur and Kollam (Kerala), and Guntur (Andhra Pradesh) in FY25.
- Guntur and Sangli O&M units contributed ₹14 crore revenue in April 25; Guntur broke even in 3 months, Sangli expected to break even in 1-2 months.
- Nashik unit is on track for guided losses, expecting to break even within 3 months after insurance empanelment is completed in the next 2 months.
- Soft launched the Thane, Mumbai unit in April, with full-fledged services expected in 5-6 months. Around 50 full-time doctors are expected to join by end of July.
- Two hospitals in Bangalore are in the final stage of completion and expected to open in the current year (July 1 and August 1 tentative). Similar doctor onboarding expected for Bangalore units.
- Opened a second unit in Vizag (KIMS Seethammadhara), a fertility center (Cuddles), and specialty centers.
- Kompally (Splendid) O&M unit is yet to be commissioned, expected towards Q3 FY26.
- New units contributed EBITDA loss of ₹18 crore in FY25, primarily in Q4.
Technology and Equipment:
- Installed South India's first Gamma Knife for non-invasive neurosurgery at KIMS Secunderabad.
- Introduced India's first MRI-guided focused ultrasound with Hero 3.0T MRI Neuro Care Center.
- First and only hospital in India to introduce TULSA-PRO for prostate treatment.
- Other equipment includes MR-Linacs and Mako Robotic Systems.
Future Outlook:
- Expecting around ₹10 crore direct addition to FY26 revenue from Guntur and Sangli.
- Nashik and Kerala units are expected to turn EBITDA positive in the next two quarters.
- Thane and Bangalore units are expected to be operational by end of Q1 FY26 and become EBITDA neutral/positive within 12 months of commissioning.
- Anticipates continued growth in Telangana cluster at around 20% (revenue and EBITDA).
- Andhra cluster ARPOB growth expected at 4%-5%, with overall revenue growth driven by ALOS reduction, payer mix, and case mix.
- Long-term revenue CAGR of 20%+ is considered achievable given bed additions and ARPOB/occupancy growth.
- Net debt as of 31st March 25 was ₹1,805 crore. Expects to add another ₹300-₹400 crore debt in FY26, reaching around ₹2,100 crore. Aims to maintain net debt to EBITDA ratio at 1:2.
- Capex over the next 2 financial years is estimated at ₹600-₹700 crore, mainly for maintenance and announced expansions (Srikakulam, Ongole, Anantapur, Kondapur medical equipment).
- Exploring further capacity expansion in Andhra (Vijayawada, Vizag), Hyderabad, Kerala, and Karnataka.